Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

CONTEXT: We have recently witnessed a rapid increase in the number of effective systemic agents for men with metastatic castration-resistant prostate cancer (CRPC), including novel hormonal therapies (abiraterone acetate and MDV3100), immunotherapies (sipu-leucel-T), chemotherapies (cabazitaxel), an...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Armstrong, Andrew J., Eisenberger, Mario A., Halabi, Susan, Oudard, Stephane, Nanus, David M., Petrylak, Daniel P., Sartor, A. Oliver, Scher, Howard I.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3445625/
https://ncbi.nlm.nih.gov/pubmed/22099611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2011.11.009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky